Giuliani Giada, Gorgoni Maurizio, Altieri Marta, Di Piero Vittorio
Department of Human Neurosciences, Sapienza University of Rome, Rome, Italy.
Department of Psychology, Sapienza University of Rome, Rome, Italy.
Front Neurol. 2023 Jul 26;14:1230710. doi: 10.3389/fneur.2023.1230710. eCollection 2023.
Cluster headache (CH) is a trigeminal autonomic cephalalgia characterized by attacks of severe unilateral pain associated with ipsilateral autonomic symptoms. Cluster headache attacks exhibit nocturnal predilection, and sleep disorders could be the first manifestation of an incipient cluster period. Sleep alterations in cluster headache patients may reflect the pivotal role of the hypothalamus, which is crucially involved in the pathophysiology of this primary headache. We describe the case of a patient affected by episodic cluster headache who experienced a sleep disorder after starting therapy with verapamil.
A 47-year-old man was affected by episodic cluster headache, characterized by attacks of excruciating pain in the left orbital and temporal regions, associated with prominent ipsilateral vegetative symptoms. Headaches occurred during the night, with one or two nocturnal attacks appearing at 11.30-12 p.m. and 4-4.30 a.m. Preventive treatment with verapamil was started, with immediate pain relief. Later, he experienced consecutive nocturnal awakenings for a couple of weeks, always at the same time, without any pain or autonomic symptoms. He was not agitated and did not need to get out of bed; after the awakenings, he reported sleep disturbances with vivid dreams.
This case represents the first description of recurrent cyclic nocturnal awakenings, without pain and autonomic symptoms, in a patient with episodic cluster headache during the active phase of a cluster bout. Nocturnal awakenings, started after the introduction of effective preventive therapy, might be an unusual form of "ghost attacks." After the beginning of prophylactic therapy, patients often describe mild pain or localized pressure in the same localization of CH attack. Similarly, the appearance of sleep disturbances, without any pain or vegetative symptoms, should be regarded as a warning sign of a still active cluster bout. Since these manifestations may influence therapeutic management, they should be carefully investigated.
丛集性头痛(CH)是一种三叉神经自主性头痛,其特征为发作性严重单侧疼痛并伴有同侧自主神经症状。丛集性头痛发作具有夜间发作倾向,睡眠障碍可能是丛集期初期的首发表现。丛集性头痛患者的睡眠改变可能反映了下丘脑的关键作用,而下丘脑在这种原发性头痛的病理生理学中至关重要。我们描述了一例发作性丛集性头痛患者在开始使用维拉帕米治疗后出现睡眠障碍的病例。
一名47岁男性患有发作性丛集性头痛,其特征为左眼眶和颞部区域发作性剧痛,并伴有明显的同侧自主神经症状。头痛发生在夜间,晚上11:30至12点以及凌晨4点至4:30会出现一到两次夜间发作。开始使用维拉帕米进行预防性治疗后,疼痛立即缓解。后来,他连续几周在同一时间出现夜间觉醒,没有任何疼痛或自主神经症状。他没有烦躁不安,也不需要起床;觉醒后,他报告有生动梦境的睡眠障碍。
该病例首次描述了一名发作性丛集性头痛患者在丛集发作活跃期出现无疼痛和自主神经症状的反复周期性夜间觉醒。在引入有效的预防性治疗后开始出现的夜间觉醒,可能是一种不寻常的“幽灵发作”形式。在预防性治疗开始后,患者常描述在丛集性头痛发作的相同部位有轻微疼痛或局部压痛。同样,出现无任何疼痛或自主神经症状的睡眠障碍,应被视为丛集发作仍活跃的警示信号。由于这些表现可能影响治疗管理,因此应仔细调查。